UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018581
Receipt number R000020409
Scientific Title The importance of home blood pressure in patients with diabetes.
Date of disclosure of the study information 2015/08/07
Last modified on 2016/08/07 10:00:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The importance of home blood pressure in patients with diabetes.

Acronym

home blood pressure in patients with diabetes.

Scientific Title

The importance of home blood pressure in patients with diabetes.

Scientific Title:Acronym

home blood pressure in patients with diabetes.

Region

Japan


Condition

Condition

diabetes mellitus

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the present study is to provide an innovative thrapeutic means for the prevention and treatment of microvascular and macrovascular complications in patients with diabetes mellitus.

Basic objectives2

Others

Basic objectives -Others

The aim of the present study is to compare the effects on home blood pressure and home blood pressure variability of combination therapy of olmesartan combined with azelnidipine or trichlormethiazide in patients with type 2 diabetes mellitus using home blood pressure telemonitoring system.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

home blood pressure and home blood pressure variability at least 28 days after randomization or switching drugs.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

olmesartan 20mg and azelnidipine 16mg, olmesartan 20mg and trichlormethiazide 1mg for more than 6 weeks each
We used HBP data at least 28 days after randomization or switching drugs.

Interventions/Control_2

olmesartan 20mg and trichlormethiazide 1mg, olmesartan 20mg and azelnidipine 16mg for more than 6 weeks each
We used HBP data at least 28 days after randomization or switching drugs.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Inclusion criteria were as follows: 40-80 years, type 2 diabetes mellitus, hypertension with the use of RAS inhibitors, RAS inhibitors and CCBs, or RAS inhibitors and diuretics.

Key exclusion criteria

Exclusion criteria were as follows: secondary hypertension or malignant hypertension, history of cerebrovascular accident, myocardial infarction or hospitalization for angina pectoris within 6 months before evaluation for study entry, advanced liver or renal dysfunction (serum creatinine equal to or more than 2.0mg/dl or current treatment by dialysis), atrial fibrillation or severe arrhythmia, prescribed 3 and over antihypertensive drugs, prescribed other class of antihypertensive drugs than study drugs (that is, RAS inhibitors, CCBs or diuretics), history of side effects from study drugs, life-threatening condition like malignant tumor or not suited to be a study patients as judged by a physician in charge.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michiaki Fukui

Organization

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Division name

Department of Endocrinology and Metabolism

Zip code


Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan

TEL

075-251-5505

Email

michiaki@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Emi Ushigome

Organization

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Division name

Department of Endocrinology and Metabolism

Zip code


Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan

TEL

075-251-5505

Homepage URL


Email

emis@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Emi Ushigome received grant support from Japanese Study Group for Physiology and Management of Blood Pressure and Astellas Foundation for Research on Metabolic Disorders.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 07 Day

Last modified on

2016 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020409


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name